Literature DB >> 27042498

Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome.

Babak Bagheri1, Mehryar Zargari2, Fatemeh Meshkini2, Kolsoum Dinarvand2, Vahid Mokhberi1, Soheil Azizi3, Mehdi Rasouli2.   

Abstract

INTRODUCTION: Uric acid has antioxidant activity and it is expected to protect against coronary artery disease (CAD). Contradictory, it is a component of metabolic syndrome and so a risk factor for CAD. The associations of plasma total antioxidant capacity (TAOC) and uric acid (UA) as well as other risk factors were investigated relative to the occurrence and severity of CAD.
MATERIALS AND METHODS: The study population consisted of 148 males and 152 females aged 35-76 years who were classified as CAD cases and controls according to the results of coronary angiography. The severity of CAD was scored on the basis of the number and the extent of lesions at coronary arteries. The concentrations of UA and TAOC were measured by using of FRAP and enzymatic uricase methods.
RESULTS: The prevalence of hypertension, cigarette smoking and diabetes mellitus was more frequent in CAD cases than controls. Patients with CAD when compared with the controls had increased levels of glucose, triglycerides, creatinine, UA, TAOC and decreased levels of HDL- cholesterol. Serum UA was high positive correlate of serum total and LDL-cholesterol, triglyceride, creatinine, BUN, bilirubin, TAOC and negative correlate of glucose and HDL-C. TAOC and its major determinant UA but not bilirubin and albumin are significantly associated with the prevalence and severity of CAD. In multivariate analysis and in the absence of hypertension, UA but not TAOC would remain and be associated with CAD by the OR of 1.57 (1.07-2.29), p=0.02. If the results adjusted for all major risk factors including hypertension, neither TAOC nor UA would remain in the regression equation.
CONCLUSION: The results suggest that TAOC and UA but not bilirubin and albumin are associated with CAD significantly. But, the correlation is not independent and is attributed to the metabolic syndrome. The measurement of UA and TAOC will not improve the prognostic power beyond the classical risk factors.

Entities:  

Keywords:  Albumin; Atherosclerosis; Bilirubin; Diabetes mellitus; Oxidative stress

Year:  2016        PMID: 27042498      PMCID: PMC4800564          DOI: 10.7860/JCDR/2016/16335.7281

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  34 in total

1.  The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM.

Authors:  J Leinonen; V Rantalaiho; T Lehtimäki; T Koivula; O Wirta; A Pasternack; H Alho
Journal:  Free Radic Res       Date:  1998-10

Review 2.  Oxidative stress and cardiac disease.

Authors:  D J Lefer; D N Granger
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

3.  Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels.

Authors:  Libor Vítek; Milan Jirsa; Marie Brodanová; Milan Kalab; Zdenek Marecek; Vilém Danzig; Ladislav Novotný; Petr Kotal
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

Review 4.  Is serum uric acid a risk factor for coronary heart disease?

Authors:  S G Wannamethee
Journal:  J Hum Hypertens       Date:  1999-03       Impact factor: 3.012

Review 5.  Uric acid and cardiovascular risk.

Authors:  Michael H Alderman
Journal:  Curr Opin Pharmacol       Date:  2002-04       Impact factor: 5.547

Review 6.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

7.  Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.

Authors:  Sandip K Zalawadiya; Vikas Veeranna; Sagar Mallikethi-Reddy; Chirag Bavishi; Abhishekh Lunagaria; Anupama Kottam; Luis Afonso
Journal:  Eur J Prev Cardiol       Date:  2014-01-15       Impact factor: 7.804

8.  Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.

Authors:  Alexander M Strasak; Cecily C Kelleher; Larry J Brant; Kilian Rapp; Elfriede Ruttmann; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Int J Cardiol       Date:  2008-01-30       Impact factor: 4.164

9.  Erythrocyte Antioxidant Defenses Against Cigarette Smoking in Ischemic Heart Disease.

Authors:  Sandhya Metta; Doddamani R Basalingappa; Satyanarayana Uppala; Geeta Mitta
Journal:  J Clin Diagn Res       Date:  2015-06-01

10.  Progression of Coronary Artery Disease (CAD) from Stable Angina (SA) Towards Myocardial Infarction (MI): Role of Oxidative Stress.

Authors:  Neha Uppal; Vibha Uppal; Pankaj Uppal
Journal:  J Clin Diagn Res       Date:  2014-02-03
View more
  11 in total

1.  Elevated Uric Acid Mediates the Effect of Obesity on Hypertension Development: A Causal Mediation Analysis in a Prospective Longitudinal Study.

Authors:  Conglin Hong; Qiu Zhang; Yan Chen; Ying Lu; Linan Chen; Yan He; Jing Li; Shengqi Ma; Jun Jiang; Xiaolong Zhang; Jianwei Hu; Yi Ding; Mingzhi Zhang; Hao Peng
Journal:  Clin Epidemiol       Date:  2022-04-11       Impact factor: 5.814

2.  Life Psychosocial Stresses and Coronary Artery Disease.

Authors:  Babak Bagheri; Fatemeh Meshkini; Kolsoum Dinarvand; Zahra Alikhani; Mal Haysom; Mehdi Rasouli
Journal:  Int J Prev Med       Date:  2016-09-14

3.  The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-04

Review 4.  Prevalence of Hypertension in Cardiovascular Disease in Iran: Systematic Review and Meta-Analysis.

Authors:  Moloud Fakhri; Diana Sarokhani; Bahareh Ghiasi; Ali Hasanpour Dehkordi
Journal:  Int J Prev Med       Date:  2020-04-30

Review 5.  Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.

Authors:  Marine Gaudry; Donato Vairo; Marion Marlinge; Melanie Gaubert; Claire Guiol; Giovanna Mottola; Vlad Gariboldi; Pierre Deharo; Stéphane Sadrin; Jean Michel Maixent; Emmanuel Fenouillet; Jean Ruf; Regis Guieu; Franck Paganelli
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

6.  Serum Creatinine and Occurrence and Severity of Coronary Artery Disease.

Authors:  Babak Bagheri; Najme Radmard; Atena Faghani-Makrani; Mehdi Rasouli
Journal:  Med Arch       Date:  2019-06

Review 7.  Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?

Authors:  Franck Paganelli; Giovanna Mottola; Julien Fromonot; Marion Marlinge; Pierre Deharo; Régis Guieu; Jean Ruf
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

8.  Evaluation of the serum levels of Mannose binding lectin-2, tenascin-C, and total antioxidant capacity in patients with coronary artery disease.

Authors:  Hamed Mehri; Naser Aslanabadi; Alireza Nourazarian; Behrouz Shademan; Fatemeh Khaki-Khatibi
Journal:  J Clin Lab Anal       Date:  2021-09-07       Impact factor: 2.352

Review 9.  The Potential of Prognostic Biomarkers of Uric Acid Levels in Coronary Heart Disease Among Aged Population: A Scoping Systematic Review of the Latest Cohort Evidence.

Authors:  Sidik Maulana; Aan Nuraeni; Bambang Aditya Nugraha
Journal:  J Multidiscip Healthc       Date:  2022-01-26

10.  Association of serum uric acid with nephropathy in Iranian type 2 diabetic patients.

Authors:  Farideh Razi; Ensieh Nasli-Esfahani; Fatemeh Bandarian
Journal:  J Diabetes Metab Disord       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.